Morrison Foerster
  • People
  • Capabilities
    PracticesIndustries + IssuesRegions
  • Resources
    InsightsNewsEventsBlogsPodcastsVideo + Audio
  • About
    Chair, Vice Chairs, COOOur ValuesHonors + AwardsPress Contacts
  • Culture
    MoFo WomenDiversityMoFo FoundationPro Bono
  • Offices
  • Careers
  • Alumni
  • Contact
Stay Connected

Public Companies Counseling & Compliance Resources

  • Email

Our lawyers, who counsel public companies and their boards of directors in all aspects of regulatory compliance, provide their insights on the latest developments in regards to securities disclosures and compliance with government and stock exchange requirements in light of the coronavirus (COVID-19) pandemic.

Client Alerts

  • Coronavirus (COVID-19): U.S. SEC Staff Statements on Public Company Disclosure and Financial Reporting, 1 July 2020
  • Coronavirus (COVID-19): U.S. SEC and States Provide Further Relief for Upcoming Annual Shareholder Meetings, 17 April 2020
  • Coronavirus (COVID-19): Liability Management Considerations, 16 April 2020
  • Coronavirus (COVID-19): ISS and Glass Lewis Adopt Policy Changes for the 2020 Proxy Season, 14 April 2020
  • SEC Staff Guidance Regarding the Filing of Form 144 in Light of COVID-19, 13 April 2020
  • COVID-19: SEC Statements on Public Company Disclosure and Financial Reporting, 12 April 2020
  • Coronavirus (COVID-19) and Stock Repurchase Programs, 2 April 2020
  • Coronavirus (COVID-19): Preparing for Form 8-K Disclosures, 1 April 2020
  • Coronavirus (COVID-19): Dealing with Customers in Financial Distress, 31 March 2020
  • SEC Eases Compliance with Form ID, Regulation A, and Regulation Crowdfunding Requirements, 30 March 2020
  • SEC Extends Conditional Exemptions for Exchange Act Filings and Proxy Materials, 26 March 2020
  • Guidance for Public Companies on Signatures and Disclosure Considerations in Light of COVID-19, 26 March 2020
  • COVID-19: Liquidity Issues and Debt Incurrence Capacity in High Yield Bonds, 26 March 2020
  • Coronavirus (COVID-19) Considerations for Shareholder Proposals, 23 March 2020
  • Coronavirus (COVID-19): How Delays in Processing of Filings May Impact Transactions, 20 March 2020
  • COVID-19 (Coronavirus): A Practical Checklist for Directors, 19 March 2020
  • SEC Guidance on Annual Meeting Changes Due to COVID-19, 18 March 2020
  • What Companies Need to Know Now About Public Disclosures Concerning COVID-19, 17 March 2020
  • COVID-19 and Rule 10b5-1 Plans: Best Practices, 16 March 2020
  • Disclosure and Governance Hot Topics for Public Companies in 2020, 25 Feb 2020

Press + News

  • Practical Tips for Virtual Oversights (Article), 1 April 2020
  • So Your Company’s CEO Has Coronavirus. Does the World Have to Know? (Article), 25 March 2020
  • Why In-House Counsel Need to Watch for Insider Trading, Public Disclosure Issues From COVID-19 (Article), 11 March 2020
  • Coronavirus (COVID-19) Resource Center
  • Coronavirus (COVID-19) Resource Center
  • Terms / Notices
  • Cookies
  • Privacy Policy
  • Attorney Advertising
  • Secure Login
  • Alumni

©1996–2023 Morrison & Foerster LLP. All rights reserved.